Sharlene Gill, MD, MPH, MBA, FASCO(@GillSharlene) 's Twitter Profile Photo

ASCO
Dr. Jennifer Knox, IIT 🇨🇦
📌 multiomic profiling, Rph2 mFFX vs GnP
📌 n=160, ~30% basal/70% classical
👉early results - PFS/OS - mFFX was not better than GnP in this cohort excl gBRCA/PALB2
👉outcomes in pancreatic cancer remain poor
👏rich

#ASCO24 @ASCO #PCsm 
#PASS01 Dr. Jennifer Knox, IIT 🇨🇦
📌 multiomic profiling, Rph2 mFFX vs GnP
📌 n=160, ~30% basal/70% classical
👉early results - PFS/OS - mFFX was not better than GnP in this cohort excl gBRCA/PALB2
👉outcomes in pancreatic cancer remain poor
👏rich
account_circle
Jahana Hayes(@RepJahanaHayes) 's Twitter Profile Photo

Birth control:
✅ Improves health outcomes
✅ Promotes gender equity
✅ Ensures bodily autonomy

Today, I signed a discharge petition to bring the Right to Contraception Act to the floor and finally codify the right to birth control under federal law.

Birth control:
✅ Improves health outcomes
✅ Promotes gender equity
✅ Ensures bodily autonomy

Today, I signed a discharge petition to bring the Right to Contraception Act to the floor and finally codify the right to birth control under federal law.
account_circle
Dr. Dale Bredesen(@DrDaleBredesen) 's Twitter Profile Photo

Consumption of Ultraprocessed foods (UPFs) is increasing worldwide even though the link between UPFs and negative outcomes has been clear for some time. Find a healthier snack, your brain will thank you for it! medscape.com/viewarticle/ul…

Consumption of Ultraprocessed foods (UPFs) is increasing worldwide even though the link between UPFs and negative outcomes has been clear for some time. Find a healthier snack, your brain will thank you for it! medscape.com/viewarticle/ul…
account_circle
Stroke AHA/ASA(@StrokeAHA_ASA) 's Twitter Profile Photo

🧵 : In a retrospective observational cohort study of patients without CTP-mismatch profiles (defined according to the EXTEND criteria), recanalization was associated with improved functional outcomes.

🧵#STROKE: In a retrospective observational cohort study of patients without CTP-mismatch profiles (defined according to the EXTEND criteria), recanalization was associated with improved functional outcomes.
account_circle
UroToday.com(@urotoday) 's Twitter Profile Photo

Impact of alterations in tumor suppressor genes on survival outcomes in patients with de novo cancer receiving ADT with ARPI or docetaxel. Presentation by Arshit Narang AIIMS, New Delhi. written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3V8pdKf ASCO

Impact of alterations in tumor suppressor genes on survival outcomes in patients with de novo #mCSPC cancer receiving ADT with ARPI or docetaxel. Presentation by @Arshit3321 @aiims_newdelhi. #ASCO24 written coverage by @zklaassen_md @GACancerCenter > bit.ly/3V8pdKf @ASCO
account_circle
Complete Maths(@LaSalleEd) 's Twitter Profile Photo

We're excited to announce another workshop! This one will be run by Adam Brown and Adam Mercer !

🧮 Teach (Maths) Like a Champion: A Playbook for Great Outcomes

🎟️ Book your ticket today:
completemaths.com/community/math…

We're excited to announce another #MathsConf35 workshop! This one will be run by @APBmaths and @AMercerMaths !

🧮 Teach (Maths) Like a Champion: A Playbook for Great Outcomes

🎟️ Book your ticket today: 
completemaths.com/community/math…
account_circle
Deniz Can Guven(@DenizCanGuven1) 's Twitter Profile Photo

Live from and Track 🔥🔥
Early results from PASS-01 study by Jennifer J. Knox

Signature-based treatment selection in mPDAC🖋️🖋️

☑️Very detailed biomarker studies 🧬🧬
☑️Inferior outcomes with FFX in basal type
☑️Correlate-guided therapy MTBs in 50% of the

Live from #ASCO24 #GE and #HPB Track 🔥🔥
Early results from PASS-01 study by Jennifer J. Knox

Signature-based treatment selection in mPDAC🖋️🖋️

☑️Very detailed biomarker studies 🧬🧬
☑️Inferior outcomes with FFX in basal type
☑️Correlate-guided therapy MTBs in 50% of the
account_circle
Multiple Myeloma Hub(@MM_Hub) 's Twitter Profile Photo

CONGRESS | | marivi mateos Universidad de Salamanca shares a subgroup analysis from DREAMM-7 of BVd vs DVd in RRMM; concluding that BVd resulted in improved PFS and OS. BVd also resulted in improved outcomes in patients with poor prognostic features compared with DVd.

CONGRESS | #ASCO24 | @mvmateos @usal shares a subgroup analysis from DREAMM-7 of BVd vs DVd in RRMM; concluding that BVd resulted in improved PFS and OS. BVd also resulted in improved outcomes in patients with poor prognostic features compared with DVd.
#mmsm #myeloma
account_circle
Ramon Bataller(@rabataller) 's Twitter Profile Photo

Can we assess liver fibrosis and predict outcomes just using blood-based tests?

These two papers show that FIB-4 plus ELF accurately assess fibrosis and predict decompensation and mortality.

t.ly/T9-p8 t.ly/5nlgu

Can we assess liver fibrosis and predict outcomes just using blood-based tests?

These two papers show that FIB-4 plus ELF accurately assess fibrosis and predict decompensation and mortality.

t.ly/T9-p8 t.ly/5nlgu #livertwitter
account_circle
Neurology Journal(@GreenJournal) 's Twitter Profile Photo

Neurology Podcast: Dr. Dan Ackerman and Dr. Silja Räty discuss the outcomes of patients with BAO treated with IVT only and compares IVT with endovascular thrombectomy. Listen now: bit.ly/3Vs1FBo Article: bit.ly/45gTtHC
Dr. Daniel Ackerman MD FAAN

account_circle
Prof. E. Kofi Abotsi(@ProfAbotsi) 's Twitter Profile Photo

Excessive transparency can never be bad in any electoral process. In a country where losing parties have always questioned electoral outcomes since 1993, it is a counterintuitive proposition for the EC to seek to go it alone for the parties to follow. turnaround

account_circle
Yale Cancer Center(@YaleCancer) 's Twitter Profile Photo

.Amin Nassar, MD explores treatment options for 1st line treatment of advanced pure large cell neuroendocrine carcinoma revealing similar outcomes for chemo, IO & chemoIO, questioning the added benefit of chemoIO compared to chemo alone Anne Chiang OncoAlert

.@AminNassarMD explores treatment options for 1st line treatment of advanced pure large cell neuroendocrine carcinoma #ASCO24 revealing similar outcomes for chemo, IO & chemoIO, questioning the added benefit of chemoIO compared to chemo alone @Annechiangmd @OncoAlert
account_circle
UroToday.com(@urotoday) 's Twitter Profile Photo

Avelumab first line maintenance for advanced : Long-term outcomes from the Bladder 100 Trial in patients with histological subtypes. Presented by ylt Gustave Roussy > bit.ly/3VsbwXU Zach Klaassen

Avelumab first line maintenance for advanced #UrothelialCarcinoma: Long-term outcomes from the #JAVELIN Bladder 100 Trial in patients with histological subtypes. Presented by @y_loriot @GustaveRoussy > bit.ly/3VsbwXU @zklaassen_md #ASCO24
account_circle
Ophthalmology(@AAOjournal) 's Twitter Profile Photo

Cellular Determinants of Visual Outcomes in Eyes with Epiretinal Membrane: Insights from Adaptive Optics Optical Coherence Tomography
ow.ly/XAb950RnZcw

Cellular Determinants of Visual Outcomes in Eyes with Epiretinal Membrane: Insights from Adaptive Optics Optical Coherence Tomography
ow.ly/XAb950RnZcw
account_circle
Extramural Research(@NIHgrants) 's Twitter Profile Photo

Institutional training data tables will be updated to reduce burden, focus on trainee outcomes, and promote consistent information collection across training programs.🔎

Learn more about upcoming changes at tomorrow's webinar! Register now: grants.nih.gov/learning-cente…

Institutional training data tables will be updated to reduce burden, focus on trainee outcomes, and promote consistent information collection across training programs.🔎

Learn more about upcoming changes at tomorrow's webinar! Register now: grants.nih.gov/learning-cente…
account_circle